UBC Faculty Research and Publications

Intravenous (IV) iron for severe iron deficiency Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 97 examines intravenous (IV) iron for severe iron deficiency. Conclusions Intravenous iron markedly benefits appropriately selected people with chronic severe iron deficiency. Rare but potentially fatal reactions occur with all IV iron products. This requires administration in a setting where immediate treatment is available, including adrenaline. No formulation is proven to be safer than others. IV iron is preferable to IM injection.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International